Atopic dermatitis, naevi count and skin cancer risk: A meta-analysis

Sara Gandini, Ignazio Stanganelli, Domenico Palli, Vincenzo De Giorgi, Giovanna Masala, Saverio Caini

Research output: Contribution to journalArticle

Abstract

Background The risk of skin malignancy among atopic dermatitis (AD) patients is not well established. Objective We reviewed the epidemiological evidence on the association between AD, naevi count, and the risk of cutaneous melanoma and keratinocyte skin cancer (KSC). Methods We included all studies that compared the naevi count and the risk of skin cancer (melanoma and/or KSC) between AD patients and unaffected individuals. We calculated summary relative risks (SRRs) and 95% confidence intervals (CI) through random effects models; explored correlates of between-studies heterogeneity using sub-group and sensitivity analysis; and assessed publication bias using a funnel-plot-based approach. Results The number of common naevi larger ≥2 mm on the whole body was consistently lower among AD patients vs. unaffected individuals when measured by trained health professionals. The risk of melanoma was not increased among AD patients (SRR = 0.77, 95%CI 0.44–1.35, I2 = 85%). We found a significantly increased risk of basal cell cancer (BCC) (SRR = 1.34, 95%CI 1.03–1.75, I2 = 24.0%) but not for squamous cell cancer (SRR = 1.91, 95% CI 0.74–4.91, I2 = 0.0%); however, only a few papers adjusted for phenotypic characteristics and/or sunlight exposure. We found no evidence of publication bias. Conclusions AD patients may be at increased BCC risk; however, methodological limitations prevented from drawing definitive conclusions. Despite the lack of strong scientific evidence, AD patients should avoid excessive sun exposure, regularly perform skin self examination, and consult a doctor in case of a suspicious skin lesion.

Original languageEnglish
Pages (from-to)137-143
Number of pages7
JournalJournal of Dermatological Science
Volume84
Issue number2
DOIs
Publication statusPublished - Nov 1 2016

Fingerprint

Nevus
Skin Neoplasms
Atopic Dermatitis
Meta-Analysis
Skin
Basal Cell Neoplasms
Confidence Intervals
Publication Bias
Melanoma
Keratinocytes
Self-Examination
Squamous Cell Neoplasms
Sunlight
Solar System
Sun
Sensitivity analysis
Cells
Health

Keywords

  • Atopic dermatitis
  • Cutaneous melanoma
  • Keratinocyte skin cancer
  • Meta-analysis
  • Naevi count

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Dermatology

Cite this

Atopic dermatitis, naevi count and skin cancer risk : A meta-analysis. / Gandini, Sara; Stanganelli, Ignazio; Palli, Domenico; De Giorgi, Vincenzo; Masala, Giovanna; Caini, Saverio.

In: Journal of Dermatological Science, Vol. 84, No. 2, 01.11.2016, p. 137-143.

Research output: Contribution to journalArticle

Gandini, Sara ; Stanganelli, Ignazio ; Palli, Domenico ; De Giorgi, Vincenzo ; Masala, Giovanna ; Caini, Saverio. / Atopic dermatitis, naevi count and skin cancer risk : A meta-analysis. In: Journal of Dermatological Science. 2016 ; Vol. 84, No. 2. pp. 137-143.
@article{9eef1d36b21d4bb3a5048b7281409c18,
title = "Atopic dermatitis, naevi count and skin cancer risk: A meta-analysis",
abstract = "Background The risk of skin malignancy among atopic dermatitis (AD) patients is not well established. Objective We reviewed the epidemiological evidence on the association between AD, naevi count, and the risk of cutaneous melanoma and keratinocyte skin cancer (KSC). Methods We included all studies that compared the naevi count and the risk of skin cancer (melanoma and/or KSC) between AD patients and unaffected individuals. We calculated summary relative risks (SRRs) and 95{\%} confidence intervals (CI) through random effects models; explored correlates of between-studies heterogeneity using sub-group and sensitivity analysis; and assessed publication bias using a funnel-plot-based approach. Results The number of common naevi larger ≥2 mm on the whole body was consistently lower among AD patients vs. unaffected individuals when measured by trained health professionals. The risk of melanoma was not increased among AD patients (SRR = 0.77, 95{\%}CI 0.44–1.35, I2 = 85{\%}). We found a significantly increased risk of basal cell cancer (BCC) (SRR = 1.34, 95{\%}CI 1.03–1.75, I2 = 24.0{\%}) but not for squamous cell cancer (SRR = 1.91, 95{\%} CI 0.74–4.91, I2 = 0.0{\%}); however, only a few papers adjusted for phenotypic characteristics and/or sunlight exposure. We found no evidence of publication bias. Conclusions AD patients may be at increased BCC risk; however, methodological limitations prevented from drawing definitive conclusions. Despite the lack of strong scientific evidence, AD patients should avoid excessive sun exposure, regularly perform skin self examination, and consult a doctor in case of a suspicious skin lesion.",
keywords = "Atopic dermatitis, Cutaneous melanoma, Keratinocyte skin cancer, Meta-analysis, Naevi count",
author = "Sara Gandini and Ignazio Stanganelli and Domenico Palli and {De Giorgi}, Vincenzo and Giovanna Masala and Saverio Caini",
year = "2016",
month = "11",
day = "1",
doi = "10.1016/j.jdermsci.2016.07.009",
language = "English",
volume = "84",
pages = "137--143",
journal = "Journal of Dermatological Science",
issn = "0923-1811",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Atopic dermatitis, naevi count and skin cancer risk

T2 - A meta-analysis

AU - Gandini, Sara

AU - Stanganelli, Ignazio

AU - Palli, Domenico

AU - De Giorgi, Vincenzo

AU - Masala, Giovanna

AU - Caini, Saverio

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Background The risk of skin malignancy among atopic dermatitis (AD) patients is not well established. Objective We reviewed the epidemiological evidence on the association between AD, naevi count, and the risk of cutaneous melanoma and keratinocyte skin cancer (KSC). Methods We included all studies that compared the naevi count and the risk of skin cancer (melanoma and/or KSC) between AD patients and unaffected individuals. We calculated summary relative risks (SRRs) and 95% confidence intervals (CI) through random effects models; explored correlates of between-studies heterogeneity using sub-group and sensitivity analysis; and assessed publication bias using a funnel-plot-based approach. Results The number of common naevi larger ≥2 mm on the whole body was consistently lower among AD patients vs. unaffected individuals when measured by trained health professionals. The risk of melanoma was not increased among AD patients (SRR = 0.77, 95%CI 0.44–1.35, I2 = 85%). We found a significantly increased risk of basal cell cancer (BCC) (SRR = 1.34, 95%CI 1.03–1.75, I2 = 24.0%) but not for squamous cell cancer (SRR = 1.91, 95% CI 0.74–4.91, I2 = 0.0%); however, only a few papers adjusted for phenotypic characteristics and/or sunlight exposure. We found no evidence of publication bias. Conclusions AD patients may be at increased BCC risk; however, methodological limitations prevented from drawing definitive conclusions. Despite the lack of strong scientific evidence, AD patients should avoid excessive sun exposure, regularly perform skin self examination, and consult a doctor in case of a suspicious skin lesion.

AB - Background The risk of skin malignancy among atopic dermatitis (AD) patients is not well established. Objective We reviewed the epidemiological evidence on the association between AD, naevi count, and the risk of cutaneous melanoma and keratinocyte skin cancer (KSC). Methods We included all studies that compared the naevi count and the risk of skin cancer (melanoma and/or KSC) between AD patients and unaffected individuals. We calculated summary relative risks (SRRs) and 95% confidence intervals (CI) through random effects models; explored correlates of between-studies heterogeneity using sub-group and sensitivity analysis; and assessed publication bias using a funnel-plot-based approach. Results The number of common naevi larger ≥2 mm on the whole body was consistently lower among AD patients vs. unaffected individuals when measured by trained health professionals. The risk of melanoma was not increased among AD patients (SRR = 0.77, 95%CI 0.44–1.35, I2 = 85%). We found a significantly increased risk of basal cell cancer (BCC) (SRR = 1.34, 95%CI 1.03–1.75, I2 = 24.0%) but not for squamous cell cancer (SRR = 1.91, 95% CI 0.74–4.91, I2 = 0.0%); however, only a few papers adjusted for phenotypic characteristics and/or sunlight exposure. We found no evidence of publication bias. Conclusions AD patients may be at increased BCC risk; however, methodological limitations prevented from drawing definitive conclusions. Despite the lack of strong scientific evidence, AD patients should avoid excessive sun exposure, regularly perform skin self examination, and consult a doctor in case of a suspicious skin lesion.

KW - Atopic dermatitis

KW - Cutaneous melanoma

KW - Keratinocyte skin cancer

KW - Meta-analysis

KW - Naevi count

UR - http://www.scopus.com/inward/record.url?scp=84994164628&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994164628&partnerID=8YFLogxK

U2 - 10.1016/j.jdermsci.2016.07.009

DO - 10.1016/j.jdermsci.2016.07.009

M3 - Article

VL - 84

SP - 137

EP - 143

JO - Journal of Dermatological Science

JF - Journal of Dermatological Science

SN - 0923-1811

IS - 2

ER -